CNABusiness
Flagship bets £100 million on British AI drug firms

Venture firm Flagship is betting £100 million on building drug companies in Britain that use artificial intelligence. The investment signals an effort to apply the technology directly to drug development, rather than simply supporting existing firms.
This card is an AI-assisted summary of reporting published by CNA. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.